Proven
neurotechnology
built for the
real world
Control Bionics delivers objective, non-invasive neural-signal technology, proven in clinical environments, and built to scale across performance, rehabilitation, medical, research, and assistive communication.
Proven
neurotechnology
built for the
real world
Control Bionics delivers objective, non-invasive neural-signal technology, proven in clinical environments, and built to scale across performance, rehabilitation, medical, research, and assistive communication.
Capability
From signal to actionable insight
The Control Bionics neural-signal platform captures physiological data with medical-grade precision and converts it into measurable, decision-ready outcomes. Built for deployment across clinical, research, and performance environments — and validated where it counts.
Signal acquisition and processing
Real-time analysis and validation
Clinical integration and reporting
Technology
The platform serves distinct markets with precision and measurable outcomes. One underlying technology - four applications.
A platform built for clinical deployment
Medical-grade signal processing meets real-world clinical environments. Designed for integration, validation, and measurable outcomes.
Non-invasive neural signal capture
Physiological data without surgical intervention or implantation. Validated for use in complex clinical environments.
Regulatory pathway established
Cleared for clinical use with ongoing validation across multiple applications — FDA, TGA, and CE registered.
Outcome-focused architecture
Platform designed to deliver decision-ready insights, not only raw data. Built to integrate into clinical and research workflows.
Evidence from clinical and research deployment
Control Bionics technology is validated through research, clinical trials, and real-world deployment across rehabilitation, performance, and research settings.
1,000s of users
Trusted by individuals, clinicians, and organisations across four markets
Government and privately funded
Approved for funding through Medicare, Medicaid, NDIS, and private insurance pathways.
100%
Non-invasive signal acquisition
3 Regulatory clearances
(FDA, TGA, CE)
Latest from our platform
Research, clinical validation and platform developments.
NeuroNode is now an Apple-Approved Assistive Tech Device
Control Bionics is excited to announce that NeuroNode® has been listed as a third-party assistive technology device on Apple’s website. Apple’s inclusion of the NeuroNode in its Apple-approved assistive technologies underscores NeuroNode’s versatility and...
Spreading Joy with ChatCrackers
A Creative Collaboration for the Holidays If you happened to see Control Bionics’ holiday card, you saw the wonderful artwork created by Moira. Here's the card in case you missed it! The development of our holiday card this year was a joint effort between...
What to Expect during Your Trial Period
You may have thought that once the AAC evaluation was done, the next step was to complete the paperwork required by insurance to request purchase of the device. Instead, you have just been told there needs to be a trial period. What is a trial period? At its...
New HCPCS Code Approved for NeuroNode in the USA
We are thrilled to announce that NeuroNode®, our groundbreaking access solution, has been recognized with its own unique billing identifier code in the USA. This decision reflects the NeuroNode's importance and versatility in the assistive technology field. This was...
Select your path to neural-signal insights and outcomes
Explore how the platform integrates into clinical workflows and delivers decision-ready outcomes.
Learn more
Discover how researchers are using real-time neural data to power breakthrough studies.
LearnNDIS-registered provider
Control Bionics is a registered NDIS provider. Eligible participants can access our assistive communication devices and neurotechnology solutions through their NDIS plan.